UNH
49
4
FITB
43
-6
ABC
65
2
TJX
53
-2
AIG
36
-2
EMN
35
-7
APA
35
-11
TRIP
52
-5
TMO
42
-4
GILD
64
5
STT
36
-3
DD
49
-3
AVY
34
-6
CINF
22
-2
CL
48
5
DNB
30
-2
ADT
20
-2
RF
51
-2
FAST
40
3
PDCO
77
20
UNH
49
4
FITB
43
-6
ABC
65
2
TJX
53
-2
AIG
36
-2
EMN
35
-7
APA
35
-11
TRIP
52
-5
TMO
42
-4
GILD
64
5
STT
36
-3
DD
49
-3
AVY
34
-6
CINF
22
-2
CL
48
5
DNB
30
-2
ADT
20
-2
RF
51
-2
FAST
40
3
PDCO
77
20
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

Claim $10,000 in FREE Silver in 2023

Click Here to get all of the details in this FREE Kit!
Sell
48

VYGR
Voyager Therapeutics

Last Price:
12.71
Seasonality Move:
-7.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Stop Trading Like a Turtle.

Click Here to Attend Our Next Free Live A.I. Market Training

Voyager Therapeutics Price Quote

$12.71
-0.08 (0.71%)
(Updated: June 9, 2023 at 5:42 AM ET)

Voyager Therapeutics Key Stats

Sell
48
Voyager Therapeutics (VYGR) is a Sell
Day range:
$12.66 - $13.18
52-week range:
$4.61 - $14.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.66
P/B ratio:
2.57%
Volume:
744.4K
Avg. volume:
740.4K
1-year change:
126.37%
Market cap:
$556.8M
Revenue:
$40.9M
EPS:
$2.28

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 227.69%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is $76.6M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $32.4M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $27.2M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 100.61%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 45.35%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 100.61%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Data Unavailable

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 133.8%
Revenue: 22769.3% 186.63%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 12.57
Downside from Last Price: -1.71%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    36.8M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    2.5M VYGR shares are owned by insiders